MapLight Therapeutics Inc
MPLT16.980USD
+1.280+8.15%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
703.46MMarket Cap
LossP/E TTM
More Details of Company
MapLight Therapeutics Inc Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of MapLight Therapeutics Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
253.91K
-42099.00%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
248.50K
-22050.00%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
38.10K
-44616.00%
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
17.81K
-33382.00%
Dr. Timothy Garnett
Dr. Timothy Garnett
Independent Director
Independent Director
9.48K
+9478.00%
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
Dr. Christopher A. Kroeger, M.D.
Dr. Christopher A. Kroeger, M.D.
Co-Founder, President, Chief Executive Officer, Director
Co-Founder, President, Chief Executive Officer, Director
--
--
Mr. James Lillie, Ph.D.
Mr. James Lillie, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Kristopher L. Hanson
Mr. Kristopher L. Hanson
General Counsel
General Counsel
--
--
Ms. Nanna Luneborg, Ph.D.
Ms. Nanna Luneborg, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
253.91K
-42099.00%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
248.50K
-22050.00%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
38.10K
-44616.00%
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
17.81K
-33382.00%
Dr. Timothy Garnett
Dr. Timothy Garnett
Independent Director
Independent Director
9.48K
+9478.00%
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: 22 hours ago
Updated: 22 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Catalyst4 Inc
43.41%
Novo Holdings A/S
8.13%
T. Rowe Price Investment Management, Inc.
4.03%
Forbion Growth Opportunities Fund III Cooperatief UA
3.14%
The Vanguard Group, Inc.
1.92%
Other
39.37%
Shareholders
Shareholders
Proportion
Catalyst4 Inc
43.41%
Novo Holdings A/S
8.13%
T. Rowe Price Investment Management, Inc.
4.03%
Forbion Growth Opportunities Fund III Cooperatief UA
3.14%
The Vanguard Group, Inc.
1.92%
Other
39.37%
Shareholder Types
Shareholders
Proportion
Corporation
46.56%
Venture Capital
8.13%
Investment Advisor
7.72%
Individual Investor
3.21%
Investment Advisor/Hedge Fund
0.92%
Insurance Company
0.01%
Sovereign Wealth Fund
0.01%
Other
33.45%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
4
3.81M
0.06%
--
2025Q4
21
7.60M
16.75%
+7.33M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Catalyst4 Inc
19.70M
43.41%
+19.70M
--
Oct 28, 2025
Novo Holdings A/S
3.69M
8.13%
+3.69M
--
Oct 28, 2025
T. Rowe Price Investment Management, Inc.
11.80K
0.03%
+1.04K
+9.68%
Dec 31, 2025
Forbion Growth Opportunities Fund III Cooperatief UA
1.43M
3.14%
+1.43M
--
Oct 27, 2025
The Vanguard Group, Inc.
44.63K
0.1%
+23.86K
+114.87%
Nov 30, 2025
Lillie (James Woodruff)
336.19K
0.74%
+336.19K
--
Oct 27, 2025
Kreitzer (Anatol)
296.01K
0.65%
+296.01K
--
Oct 27, 2025
Kroeger (Christopher A. M.D.)
457.31K
1.01%
+457.31K
--
Oct 28, 2025
Gillis (Jonathan)
270.55K
0.6%
+270.55K
--
Oct 27, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
